Aspiro Pharma Limited recalls Ketorolac Tromethamine Injection, USP, 60 mg/2 mL (30 mg/mL), 2 mL Single-Dose Vial, For Intramuscular Use Only, Rx only
Recalled October 29, 2025 · FDA recall D-0036-2026 · Aspiro Pharma
Hazard
Presence of Particulate Matter: Particulate matter identified as glass · FDA Class II
Sold at
Nationwide within the United States
Description
Presence of Particulate Matter: Particulate matter identified as glass
Product
Ketorolac Tromethamine Injection, USP, 60 mg/2 mL (30 mg/mL), 2 mL Single-Dose Vial, For Intramuscular Use Only, Rx only, Mfd. for: Camber Pharmaceuticals, Inc., Piscataway, NJ 08854, Mfd. by: ASPIRO PHARMA LIMITED, Telangana - 502281, INDIA., U.S. Contact Number: 1-866-495-1995, NDC 31722-307-25 (Carton), 31722-307-02 (Vial label).
Manufacturer(s)
Aspiro Pharma Limited
Made in
India
Source: U.S. Food and Drug Administration. Official recall notice on fda.gov →